Federal 340B Ruling Underscores Need for Balanced Pharmacy Program
Omnicell
FEBRUARY 13, 2023
Last month, a federal appeals court in Philadelphia sided largely with pharmaceutical companies in the ongoing showdown involving access to 340B discount pricing via contract pharmacies. In light of this recent action, it is imperative for health systems to look at their pharmacy program more holistically.
Let's personalize your content